In the BioHarmony Drug Report Database
Meclizine
Antivert (meclizine) is a small molecule pharmaceutical. Meclizine was first approved as Antivert on 1982-01-01. It is used to treat motion sickness, vertigo, and vomiting in the USA. It is known to target nuclear receptor subfamily 1 group I member 3.
Trade Name
|
Antivert |
|---|---|
Common Name
|
meclizine |
ChEMBL ID
|
CHEMBL1623 |
Indication
|
motion sickness, vertigo, vomiting |
Drug Class
|
Image (chem structure or protein)